Brief: Rxsight Q4 Revenue USD 28.6 Million Vs. IBES Estimate USD 25.8 Million
Jan 07 (Reuters) - Rxsight outlook FY revenue growth 82%. * outlook FY gross margin 65-67% * outlook FY revenue USD 89.1 million
Recent news on RxSight
See all newsUS RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
Eye care company Alcon raises margin outlook, shares jump (updated)
RxSight, Inc. reports results for the quarter ended June 30 - Earnings Summary
RxSight Q2 adjusted loss beats estimates; withdraws 2026 guidance
Brief: Rxsight Inc Q2 Operating Expenses USD 39.7 Million